India agrees 'significantly lower' AstraZeneca vaccine price
“The renegotiated price is significantly lower than 200 rupees ($2.75) per dose,” Health Secretary Rajesh Bhushan told a news conference
A healthcare worker prepares to administer a dose of the Oxford University-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (COVID-19), in Santiago, Dominican Republic February 17, 2021. REUTERS/Ricardo Rojas/File Photo
The Indian government has lowered the price at which it buys AstraZeneca's Covid-19 vaccine doses being produced by the Serum Institute of India (SII), the federal health secretary said on Thursday.
"The renegotiated price is significantly lower than 200 rupees ($2.75) per dose," Health Secretary Rajesh Bhushan told a news conference.
The SII, the world's biggest vaccine maker, has licensed the vaccine from AstraZeneca and Oxford University and markets it as COVISHIELD.
Keep updated, follow The Business Standard's Google news channel
($1 = 72.6360 Indian rupees)
